In this expert Q&A, Margaret A. Lampe, RN, MsC, discusses the elimination of perinatal HIV transmission, elimination goals set out by the CDC, next steps for research, and more.
Comorbidities are a large part of the disease burden for people living with HIV. A recent study aimed to examine the prevalence of both high-risk and functional comorbidities in this patient population....
A recent study sought to examine the risk factors for with weight gain in patients beginning antiretroviral therapy for the management of HIV. Lead author Moupali Das, MD, MPH, answered our questions in...
New research indicates that many women living with HIV may prefer a monthly long-acting injectable antiretroviral therapy, once FDA-approved, instead of daily pills. Consultant360 discussed these findings...
Davide De Francesco, from University College London, answers our questions about his study on whether people with HIV experience greater age advancement than patients without HIV.
Consultant360 spoke with Keith Horvath, PhD, about his study, which indicated that technology-assisted HIV testing interventions could serve as a key strategy in reaching national and global targets for HIV...
The incidence of sexually transmitted infections has increased significantly among individuals with HIV. Carole Khaw, MD, from the Royal Adelaide Hospital answers our questions about proactively managing...
Patients with psoriasis and HIV comprise a unique subgroup that requires special consideration for treatment due to complications and comorbidities associated with both diseases, according to Wilson Liao,...
Kathleen Ryan, PhD, answered our questions about her study, which indicated that rapid scale-up of PrEP was possible without the consequence of reduced HIV testing among Australian gay, bisexual, and other...
A new study examined the relative contributions of pre-ART drug resistance mutations vs nonadherence in the etiology of elevated viral loads among pregnant women with HIV who initiate ART. Lead author...
